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Public hospitals are typically run by diagnosis-related groups (DRG) as income. There is, however, 
a major problem in that medical reimbursement per patient is dropping and at the same time the 
surgery-related costs have increased remarkably in recent years. It is therefore necessary to optimize 
income as well as reduce expenses as much as possible.
The major part of the expenses for a patient undergoing, e.g., laparoscopic rectal resection is 
divided by the intervention stage covering approximately 50% of the total expenses and the ward 
stay covering approximately 35% of the total expenses (1). It is therefore natural to focus on lowering 
ward stay as well as looking at cost containment during surgery and anesthesia. There are ongoing 
efforts to reduce ward stay in for instance optimized care regimens, so called fast-track surgery, and 
recently in the setting of the Perioperative Surgical Home that employs close collaboration between 
anesthesiology, surgery and nursing in order to send the patient home as early as possible in good 
shape.
Only a very small amount is spent on anesthesia drugs, whereas about 20 times more are spent 
on surgical devices (1). Thus, the total intervention stage expense for a laparoscopic rectal resection 
was 5,491 Euro where anesthesia only cost 123 Euro, and surgical devices cost 2,361 Euro (1). It is 
therefore important to negotiate better prices for surgical single use equipment, whereas a slight 
increase in anesthesia expense would not make a big difference to the overall budget. Thus, if anes-
thesia expenses would be increased in order to get the patients out of the operating room faster, then 
it would not matter much for the overall calculations and it would in the end be possible to run an 
extra case in that operating room. An example of this is the use of sugammadex for reversal of muscle 
relaxation in general anesthesia where the patient will be out of relaxation and anesthesia extremely 
fast, and thereby makes it possible to perform an extra surgical case if properly managed. Thus, a 
study (2) and a recent health economic assessment (3) have shown that there may be an overall 
economic benefit, even when spending more money on general anesthesia. In line with this, it is 
evident that inefficient scheduling of operating room time resulting in delays of surgery and even in 
cancelations will be very costly for the hospital (4) and especially turn over time between cases has 
a major impact of the overall operating room efficiency.
A major problem in typical operating room management is that because of working schedule, it 
is not possible to start a surgical case in the afternoon after a certain time point. The reason is fear 
of running overtime. However, it is evident that such a scenario would actually increase the surgical 
per case cost (5). The reason for this is that such a policy for operating room management will result 
in multiple cancelations of surgical cases with a subsequent reduced income to the hospital. In the 
current economic model, in most public hospitals run by DRG income the surgical department will 
receive 100% of the DRG income per case, and the anesthesia department is funded with a fixed 
budget decided by the hospital management. Thus, surgeons are bringing the income, whereas the 
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anesthesiology department will be punished if they run overtime. 
There is therefore no incitement for the anesthesia department 
to push that extra afternoon case through, because it will bear 
a risk of running overtime and paying more money for salaries. 
There is therefore an important conflict of interest between the 
surgery and the anesthesia department in the daily running of 
the OR environment, simply because the budgets are separated. 
Ideally, and in some countries, DRG “weights” and thus reim-
bursement is determined by historical costs from, e.g., the past 
3  years calculated by, e.g., the cost per patient (CPP) method. 
This makes the reimbursement more appropriate although tech-
nical improvements may not be covered. Another similar model 
with the same goal is that the surgical department buys service 
from the anesthesiology department including active operating 
minutes.
In other situations, it makes perfectly sense to increase col-
laboration between anesthesia and surgery (6), and for instance 
when developing principles of the Perioperative Surgical Home 
and other aspects of perioperative care, it gives perfectly good 
sense to work for a very close collaboration between the two 
specialties. Moreover, from a perioperative perspective of patient 
care, the separation on an anesthesiological and surgical contri-
bution to patients’ outcome becomes increasingly artificial. The 
implementation of the ERAS-protocol may lead to up to 50% 
reduction of postoperative complications (7). This protocol con-
tains both surgical specific components such as “no drains” and 
anesthesia specific components such as “mid thoracic epidural 
analgesia.” The implementation of such perioperative approaches 
could be facilitated if financing comes from a common periopera-
tive budget. Another example is the prevention of adhesions after 
laparoscopic surgery where lower intra-abdominal pressure may 
be beneficial (8) and one strategy to maintain surgical working 
space despite lower insufflation pressure is deepening neuromus-
cular block (9). Thus, the prevention of surgical complications 
may increase anesthesia-related costs and a common budget 
would facilitate such an integrated perioperative approach.
In conclusion, most hospitals are facing economic challenges 
in that income based on diagnosis-related groups are decreasing 
and expenses are increasing. We therefore have to optimize both 
income and expenses. This can be obtained by a closer collabo-
ration between surgery and anesthesia, and optimally by a full 
integration of budgets for the two departments. In this model, it 
will be favorable for all stakeholders to work for very short turn 
over time between surgical cases and utilizing the operating room 
to its absolute maximum by operating to the end of the day, and 
not stopping in the early afternoon in fear of running overtime. 
Expenses for general anesthesia are microscopic compared with 
expenses for the surgical procedure, and it may therefore be 
acceptable to increase cost of anesthesia provided that it would 
result in a faster turn over giving room for extra cases.
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